Medicare Enrolled

Dr. Julie Schwartzbard, MD

Neurology · Aventura, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
21000 NE 28TH AVE STE 205, Aventura, FL 33180
3059335993
In practice since 2005 (20 years)
NPI: 1578558821 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schwartzbard from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schwartzbard? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schwartzbard

Dr. Julie Schwartzbard is a neurology in Aventura, FL, with 20 years in practice. Based on federal Medicare data, Dr. Schwartzbard performed 268 Medicare services across 180 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schwartzbard received a total of $472,713 from 66 pharmaceutical and/or device companies across 1187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schwartzbard is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 268 Medicare services$ $472,713 industry payments

Medicare Practice Summary

Medicare Utilization ↗
268
Medicare services
Bottom 33% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
180
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)206$103$562
Office visit, established patient (20-29 min)51$71$397
Evaluation and testing for balance with recording11$90$465
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$472,713
Total received (2018-2024)
Avg $67,530/year across 7 years
Top 2% in FL for neurology
66
Companies
1,187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$332,778 (70.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$128,015 (27.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,920 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$49,502
2023
$86,474
2022
$58,905
2021
$70,173
2020
$71,865
2019
$81,585
2018
$54,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$128,485
Eisai Inc.
$108,809
Acorda Therapeutics, Inc
$43,873
Adamas Pharmaceuticals, Inc.
$28,640
Avanir Pharmaceuticals, Inc.
$26,684
Neurocrine Biosciences, Inc.
$26,663
Amneal Pharmaceuticals LLC
$18,679
AbbVie Inc.
$15,631
ACADIA Pharmaceuticals Inc
$14,657
Eli Lilly and Company
$13,313
Biohaven Pharmaceuticals, Inc.
$13,069
ABBVIE INC.
$9,747
Kyowa Kirin, Inc.
$5,686
Allergan, Inc.
$5,343
Neurocrine BioSciences, Inc.
$2,250
EISAI INC.
$1,775
Allergan Inc.
$1,109
UCB, Inc.
$963
Biohaven Pharmaceutical Holding Company Ltd.
$864
Novartis Pharmaceuticals Corporation
$716
Teva Pharmaceuticals USA, Inc.
$521
Biogen, Inc.
$454
Sunovion Pharmaceuticals Inc.
$359
GENZYME CORPORATION
$341
Amgen Inc.
$335
Alexion Pharmaceuticals, Inc.
$321
EMD Serono, Inc.
$309
Lundbeck LLC
$289
SK Life Science, Inc.
$247
PFIZER INC.
$235
US WorldMeds, LLC
$234
Boston Scientific Corporation
$190
Janssen Pharmaceuticals, Inc
$160
Mitsubishi Tanabe Pharma America, Inc.
$149
Supernus Pharmaceuticals, Inc.
$146
Upsher-Smith Laboratories LLC
$145
GE HEALTHCARE
$135
GE HealthCare
$92
Genentech USA, Inc.
$87
ARGENX US, INC.
$67
Greenwich Biosciences, Inc.
$67
MITSUBISHI TANABE PHARMA AMERICA, INC.
$67
UPSHER-SMITH LABORATORIES LLC
$62
Horizon Therapeutics plc
$56
E.R. Squibb & Sons, L.L.C.
$53
Promius Pharma LLC
$52
Abbott Laboratories
$51
Grifols USA, LLC
$49
Impax Laboratories, Inc.
$45
Otsuka America Pharmaceutical, Inc.
$44
LivaNova USA, Inc.
$43
Currax Pharmaceuticals LLC
$40
AbbVie, Inc.
$39
Avion Pharmaceuticals
$39
Mallinckrodt LLC
$30
Celgene Corporation
$28
IMPEL PHARMACEUTICALS INC.
$23
AQUESTIVE THERAPEUTICS, INC.
$21
Neurelis, Inc.
$21
CSL Behring
$20
Life Molecular Imaging Ltd
$16
Almatica Pharma LLC
$16
Octapharma USA, Inc.
$15
Vertical Pharmaceuticals, LLC
$15
Egalet US Inc
$15
ARBOR PHARMACEUTICALS, INC.
$14
Top 3 companies account for 59.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Actemra · Aimovig · BOTOX · Briviact · COMIRNATY · CONTRAVE · CREXONT · DUEXIS · DUOPA · DaTscan · Dhivy · Duopa · EMGALITY · ETERNA · Epidiolex · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA Xsail · OSMOLEX ER · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SOLIRIS · SPRIX · SYMPAZAN · Soliris · TECFIDERA · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · Utibron · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WATCHMAN · XARELTO · Xadago · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in FL.

Equivalent to $176,385 per 100 Medicare services performed
Looking for a neurology in Aventura?
Compare neurologys in the Aventura area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
297
Per 100K population
11.1
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Schwartzbard is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 2%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Schwartzbard experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Schwartzbard performed 206 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schwartzbard receive payments from pharmaceutical companies?
Yes. Dr. Schwartzbard received a total of $472,713 from 66 companies across 1,187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schwartzbard's costs compare to other neurologys in Aventura?
Dr. Schwartzbard's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schwartzbard) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →